http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2803178-B2

Outgoing Links

Predicate Object
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-465
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
filingDate 1989-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1998-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2803178-B2
titleOfInvention Antitumor substance BE-16493
priorityDate 1989-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9955
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453706507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453504357
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21866353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18471779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411493615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426068814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420297769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53816430
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447658870

Total number of triples: 28.